Unlock stock picks and a broker-level newsfeed that powers Wall Street.

HKSE - Delayed Quote HKD

AIDIGONG (0286.HK)

Compare
1.320
0.000
(0.00%)
As of February 21 at 9:42:07 AM GMT+8. Market Open.
Loading Chart for 0286.HK
  • Previous Close 1.320
  • Open 1.320
  • Bid 1.250 x --
  • Ask 1.310 x --
  • Day's Range 1.320 - 1.320
  • 52 Week Range 1.240 - 4.320
  • Volume 6,000
  • Avg. Volume 71,400
  • Market Cap (intraday) 253.683M
  • Beta (5Y Monthly) 0.37
  • PE Ratio (TTM) --
  • EPS (TTM) -1.520
  • Earnings Date Apr 14, 2025 - Apr 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Jun 22, 2020
  • 1y Target Est --

Aidigong Maternal & Child Health Limited, an investment holding company, provides postpartum care and healthcare services in the People's Republic of China. The company operates through Postpartum Care Services, Health Industry, and Other segments. It offers maternal and child healthcare services; medical anti-aging services; healthcare industry investment services; and healthcare property development services, as well as management, investment, and finance services. The company was formerly known as Common Splendor International Health Industry Group Limited and changed its name to Aidigong Maternal & Child Health Limited in December 2019. Aidigong Maternal & Child Health Limited was incorporated in 1990 and is based in Wan Chai, Hong Kong.

www.aidigong.hk

1,338

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0286.HK

View More

Performance Overview: 0286.HK

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

0286.HK
22.35%
HANG SENG INDEX (^HSI)
6.67%

1-Year Return

0286.HK
49.23%
HANG SENG INDEX (^HSI)
28.90%

3-Year Return

0286.HK
90.93%
HANG SENG INDEX (^HSI)
0.56%

5-Year Return

0286.HK
91.14%
HANG SENG INDEX (^HSI)
11.38%

Compare To: 0286.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0286.HK

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    251.76M

  • Enterprise Value

    712.26M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.33

  • Price/Book (mrq)

    0.34

  • Enterprise Value/Revenue

    1.36

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -36.96%

  • Return on Assets (ttm)

    -4.56%

  • Return on Equity (ttm)

    -22.87%

  • Revenue (ttm)

    522.09M

  • Net Income Avi to Common (ttm)

    -192.96M

  • Diluted EPS (ttm)

    -1.520

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    146.12M

  • Total Debt/Equity (mrq)

    103.72%

  • Levered Free Cash Flow (ttm)

    106.64M

Research Analysis: 0286.HK

View More

Company Insights: 0286.HK

Research Reports: 0286.HK

View More

People Also Watch